Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Cannabis Suisse (CSUI) Shares Outstanding (Diluted Average) (2016 - 2025)

Cannabis Suisse (CSUI) has disclosed Shares Outstanding (Diluted Average) for 10 consecutive years, with $205.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Diluted Average) rose 191.28% to $205.9 million in Q4 2025 year-over-year; TTM through Nov 2025 was $205.9 million, a 191.28% increase, with the full-year FY2020 number at $35.5 million, down 31.62% from a year prior.
  • Shares Outstanding (Diluted Average) was $205.9 million for Q4 2025 at Cannabis Suisse, up from $203.5 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $205.9 million in Q4 2025 to a low of $31.1 million in Q1 2022.
  • A 5-year average of $100.7 million and a median of $70.7 million in 2024 define the central range for Shares Outstanding (Diluted Average).
  • Peak YoY movement for Shares Outstanding (Diluted Average): fell 9.88% in 2022, then surged 328.72% in 2025.
  • Cannabis Suisse's Shares Outstanding (Diluted Average) stood at $34.5 million in 2021, then dropped by 9.88% to $31.1 million in 2022, then surged by 44.87% to $45.0 million in 2023, then soared by 56.92% to $70.7 million in 2024, then surged by 191.28% to $205.9 million in 2025.
  • Per Business Quant, the three most recent readings for CSUI's Shares Outstanding (Diluted Average) are $205.9 million (Q4 2025), $203.5 million (Q3 2025), and $198.3 million (Q1 2025).